Goodwill and Other Intangible Assets, net: (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
|---|
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Schedule of Movements in Goodwill |
The movements in goodwill were as follows: | | | | | | | | | | | | | | | | | | | | | | (in millions) | Europe | SSEA, CIS & MEA | EA, AU & PMI DF | Americas | Wellness & Healthcare | Total | | Balances at January 1, 2023 | $ | 4,774 | | $ | 2,869 | | $ | 493 | | $ | 10,507 | | $ | 1,012 | | $ | 19,655 | | | Changes due to: | | | | | | | | | | | | | | | Impairment | — | | — | | — | | — | | (665) | | (665) | | | Currency | 220 | | 8 | | (1) | | 89 | | 43 | | 359 | | | Measurement period adjustments | (821) | | — | | — | | (1,749) | | — | | (2,570) | | | Balances, December 31, 2023 | 4,173 | | 2,877 | | 492 | | 8,847 | | 390 | | 16,779 | | | Changes due to: | | | | | | | | Acquisitions and divestitures | — | | 512 | | — | | — | | (65) | | 447 | | | | | | | | | | Currency | (360) | | (138) | | (22) | | (98) | | (8) | | (626) | | | | | | | | | | | | | | | | | Balances, December 31, 2024 | $ | 3,813 | | $ | 3,251 | | $ | 470 | | $ | 8,749 | | $ | 317 | | $ | 16,600 | |
|
| Schedule of Amortizable Intangible Assets |
Details of other intangible assets were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | | December 31, 2023 | (in millions) | Weighted-Average Remaining Useful Life | Gross Carrying Amount | Accumulated Amortization | Net | | Gross Carrying Amount | Accumulated Amortization | Net | | Non-amortizable intangible assets | | $ | 4,446 | | | $ | 4,446 | | | $ | 4,543 | | | $ | 4,543 | | | Amortizable intangible assets: | | | | | | | | | | Trademarks | 15 years | 2,134 | | $ | 850 | | 1,284 | | | 2,267 | | $ | 784 | | 1,483 | | Reacquired commercialization rights for IQOS in the U.S. | 4 years | 2,777 | | 370 | | 2,407 | | | — | | — | | — | | | | | | | | | | | | Developed technology, including patents | 7 years | 320 | | 121 | | 199 | | | 774 | | 329 | | 445 | | | Customer relationships and other | 11 years | 3,712 | | 721 | | 2,991 | | | 3,843 | | 450 | | 3,393 | | | Total other intangible assets | | $ | 13,389 | | $ | 2,062 | | $ | 11,327 | | | $ | 11,427 | | $ | 1,563 | | $ | 9,864 | |
|
| Schedule of Non-Amortizable Intangible Assets |
Details of other intangible assets were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | | December 31, 2023 | (in millions) | Weighted-Average Remaining Useful Life | Gross Carrying Amount | Accumulated Amortization | Net | | Gross Carrying Amount | Accumulated Amortization | Net | | Non-amortizable intangible assets | | $ | 4,446 | | | $ | 4,446 | | | $ | 4,543 | | | $ | 4,543 | | | Amortizable intangible assets: | | | | | | | | | | Trademarks | 15 years | 2,134 | | $ | 850 | | 1,284 | | | 2,267 | | $ | 784 | | 1,483 | | Reacquired commercialization rights for IQOS in the U.S. | 4 years | 2,777 | | 370 | | 2,407 | | | — | | — | | — | | | | | | | | | | | | Developed technology, including patents | 7 years | 320 | | 121 | | 199 | | | 774 | | 329 | | 445 | | | Customer relationships and other | 11 years | 3,712 | | 721 | | 2,991 | | | 3,843 | | 450 | | 3,393 | | | Total other intangible assets | | $ | 13,389 | | $ | 2,062 | | $ | 11,327 | | | $ | 11,427 | | $ | 1,563 | | $ | 9,864 | |
|